The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution

[1]  Trond Brattelid,et al.  5-HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  D. Middlemiss,et al.  5‐CT stimulation of adenylyl cyclase activity in guinea‐pig hippocampus: evidence for involvement of 5‐HT7 and 5‐HT1A receptors , 1999, British journal of pharmacology.

[3]  J. Villemure,et al.  Multiple Microvascular and Astroglial 5-Hydroxytryptamine Receptor Subtypes in Human Brain: Molecular and Pharmacologic Characterization , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  J. Terrón,et al.  Pharmacological evidence for the 5‐HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries , 1999, British journal of pharmacology.

[5]  J. Bockaert,et al.  Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. , 1999, Molecular pharmacology.

[6]  J. Heiligers,et al.  Changes in systemic and regional haemodynamics during 5-HT7 receptor-mediated depressor responses in rats , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[7]  S. Nawoschik,et al.  Identification of a human 5-HT6 receptor variant produced by alternative splicing. , 1999, Brain research. Molecular brain research.

[8]  L. Schechter,et al.  Cloning, mRNA localization and evolutionary conservation of a human 5-HT7 receptor pseudogene. , 1999, Gene.

[9]  P. Szot,et al.  Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing , 1998, Neuropharmacology.

[10]  T. Branchek,et al.  Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation. , 1998, The Journal of pharmacology and experimental therapeutics.

[11]  P. Saxena,et al.  5-HT1-like receptors: a time to bid goodbye. , 1998, Trends in pharmacological sciences.

[12]  J. Hagan,et al.  Functional characterisation of the human cloned 5‐HT7 receptor (long form); antagonist profile of SB‐258719 , 1998, British journal of pharmacology.

[13]  R. Fischmeister,et al.  Cloning, Expression, and Pharmacology of Four Human 5‐Hydroxytryptamine4 Receptor Isoforms Produced by Alternative Splicing in the Carboxyl Terminus , 1998, Journal of neurochemistry.

[14]  R. Eglen,et al.  Cloning, expression and pharmacology of a truncated splice variant of the human 5‐HT7 receptor (h5‐HT7(b)) , 1997 .

[15]  W. Olijve,et al.  Human serotonin 5‐HT7 receptor: cloning and pharmacological characterisation of two receptor variants , 1997, FEBS letters.

[16]  G. Martin,et al.  The 5-HT7 receptor: orphan found. , 1997, Trends in pharmacological sciences.

[17]  J. Heiligers,et al.  Characterization of putative 5‐HT7 receptors mediating tachycardia in the cat , 1997, British journal of pharmacology.

[18]  R. Emeson,et al.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing , 1997, Nature.

[19]  P. Molenaar,et al.  Modulation of human cardiac function through 4 β-adrenoceptor populations , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[20]  R. Kohen,et al.  Four 5‐Hydroxytryptamine7 (5‐HT7) Receptor Isoforms in Human and Rat Produced by Alternative Splicing: Species Differences Due to Altered Intron‐Exon Organization , 1997, Journal of neurochemistry.

[21]  G. Gabbiani,et al.  Functional, endogenously expressed 5‐hydroxytryptamine 5‐ht7 receptors in human vascular smooth muscle cells , 1996, British journal of pharmacology.

[22]  H. Lübbert,et al.  Expression of serotonin receptor mRNAs in blood vessels , 1995, FEBS letters.

[23]  R. Eglen,et al.  Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum. , 1995, European journal of pharmacology.

[24]  H. Kao,et al.  The 5‐HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. , 1995, The EMBO journal.

[25]  A. Tsou,et al.  Cloning and Expression of a 5‐Hydroxytryptamine7 Receptor Positively Coupled to Adenylyl Cyclase , 1994, Journal of neurochemistry.

[26]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[27]  T. Branchek,et al.  Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. , 1993, The Journal of biological chemistry.

[28]  J. Schwartz,et al.  Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Erlander,et al.  A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms , 1993, Neuron.

[30]  D. Sibley,et al.  Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. , 1993, The Journal of biological chemistry.

[31]  J. Plassat,et al.  Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. , 1993, Molecular pharmacology.

[32]  W. Meyerhof,et al.  A novel rat serotonin receptor: primary structure, pharmacology, and expression pattern in distinct brain regions. , 1993, DNA and cell biology.

[33]  A. Themmen,et al.  In situ assay of hormone-stimulated adenylyl cyclase in 96-well microtitration plates: an aide to rapid identification of transformed cell clones. , 1993, Journal of receptor research.

[34]  J. Bockaert,et al.  Adenylyl cyclase activities in ovarian tissues. I. Homogenization and conditions of assay in graafian follicles and corpora lutea of rabbits, rats, and pigs: regulation by ATP, and some comparative properties. , 1976, Endocrinology.

[35]  J. Bockaert,et al.  Hormone-stimulated desensitization of hormone-dependent adenylyl cyclase. Dual action of luteninizing hormone on pig graafian follicle membranes. , 1976, The Journal of biological chemistry.

[36]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.

[37]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[38]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .